Latest news
Arrowstreet Capital Limited Partnership Takes Position in Atea Pharmaceuticals, Inc. $AVIR - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:34:35 GMTAtea Pharmaceuticals Leads Our Trio Of Promising Penny Stocks - simplywall.stsimplywall.st · Wed, 05 Aug 2026 17:17:36 GMTAtea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026 - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 11:17:00 GMTAnalysts Are Bullish on These Healthcare Stocks: Opko Health (OPK), Atea Pharmaceuticals (AVIR) - The Globe and MailThe Globe and Mail · Wed, 29 Jul 2026 15:14:00 GMT301,699 Shares in Atea Pharmaceuticals, Inc. $AVIR Bought by Irenic Capital Management LP - MarketBeatMarketBeat · Wed, 29 Jul 2026 10:48:49 GMTAtea's hepatitis C combination meets non-inferiority bar, clears path to regulatory filing - AllSciAllSci · Wed, 29 Jul 2026 09:05:26 GMTAtea reports positive topline results in Phase III hepatitis C study - Clinical Trials ArenaClinical Trials Arena · Wed, 29 Jul 2026 07:00:00 GMTAtea Pharmaceuticals Reports Positive Topline Results From C-BEYOND Phase 3 Trial Evaluating Bemnifosbuvir/Ruzasvir For Hepatitis C Virus - marketscreener.commarketscreener.com · Tue, 28 Jul 2026 13:26:12 GMT